XML 130 R116.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Share-Based Compensation Arrangements by Share Based Payment Award) (Details)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Equity Awards Vested and Expected to Vest, Awards | shares 1,841
Equity Awards Vested and Expected to Vest, Average Price | $ / shares $ 78.33
Equity Awards Vested and Expected to Vest, Average Intrinsic Value | $ $ 8
Equity Awards Vested and Expected to Vest, Remaining Term 7 years 8 months 15 days
Equity Awards That Are Exercisable, Awards | shares 1,029
Equity Awards That Are Exercisable, Average Price | $ / shares $ 76.04
Equity Awards That Are Exercisable, Aggregate Intrinsic Value | $ $ 11
Equity Awards That Are Exercisable, Remaining Term 4 years 3 months 18 days
Stock Appreciation Rights (SARs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Number | shares 32,860
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares $ 78.60
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ $ 155
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term 7 years 9 months 25 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable, Number | shares 19,276
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Exercise Price | $ / shares $ 77.34
Equity Awards That Are Exercisable, Aggregate Intrinsic Value | $ $ 176
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Remaining Contractual Term 4 years 5 months 15 days
Performance Share Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Number | shares 1,127
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares $ 73.76
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ $ 97
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term 2 years 1 month 9 days
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Number | shares 10,660
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares $ 66.29
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ $ 1,174
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term 1 year 7 months 9 days